Skip to main content

Table 2 Primary and secondary outcomes

From: 'Which treatment do you believe you received?' A randomised blinding feasibility trial of spinal manual therapy

Outcome

Active SMT

(n = 40)

Placebo SMT

(n = 41)

Overall

(95% CI)

Primary outcome

   

Bang BI of participants—study visit 1a

0.50 (0.26 to 0.74)

0.37 (0.10 to 0.63)

Sum BI, 0.87 (0.51 to 1.23)

Bang BI of participants—study visit 2a

0.36 (0.08 to 0.64)

0.29 (0.01 to 0.57)

Sum BI, 0.65 (0.26 to 1.04)

Secondary outcomes

   

James BI of participants—study visit 1b

  

0.35 (0.24 to 0.45)

James BI of participants—study visit 2b

  

0.37 (0.27 to 0.48)

Bang BI of outcome assessors—study visit 1c

0.08 (− 0.05 to 0.20)

− 0.12 (− 0.24 to − 0.00)

Sum BI, − 0.04 (− 0.22 to 0.14)

Bang BI of outcome assessors—study visit 2c

0.03 (− 0.11 to 0.16)

− 0.07 (− 0.21 to 0.07)

Sum BI, − 0.04 (− 0.23 to 0.15)

James BI of outcome assessors—study visit 1c

  

0.93 (0.87 to 0.98)

James BI of outcome assessors —study visit 2c

  

0.91 (0.85 to 0.97)

Other participant outcomes

Active SMT

(n = 40)

Placebo SMT

(n = 41)

Effect

(95% CI)

Credibility—study visit 2, mean (SD)d

6.40 (1.76)

4.91 (2.50)

MD, 1.49 (0.55 to 2.43)

Expectancy—study visit 2, mean (SD)e

6.17 (1.65)

4.84 (2.54)

MD, 1.33 (0.40 to 2.26)

Credibility/Expectancy—study visit 2, mean (SD)f

6.29 (1.66)

4.87 (2.49)

MD, 1.42 (0.50 to 2.34)

Change in ROM—degrees, mean (SD)g

   

Flexion

− 2.72 (11.65)

0.07 (10.36)

MD, − 2.79 (− 7.63 to 2.05)

Extension

− 0.03 (6.39)

0.73 (8.57)

MD, − 0.76 (− 4.06 to 2.54)

Total

− 2.74 (13.98)

0.80 (14.99)

MD, − 3.54 (− 9.89 to 2.81)

  1. BI blinding index, CEQ Credibility/Expectancy Questionnaire, MD mean difference
  2. aFrom responses to the questions 'Which treatment do you believe you received?'; Bang BI ranges from –1 (all incorrect beliefs) to 1 (all correct beliefs); values between − 0.3 and 0.3 may be suggestive of 'adequate' blinding
  3. bFrom responses to the question 'Which treatment do you believe you received?'; James BI ranges from 0 (all correct beliefs) to 1 (all 'Do not know' beliefs); when 50% of beliefs are correct, and 50% incorrect, James BI returns 0.5
  4. cFrom responses to the question 'Which treatment do you believe this participant received?'
  5. dCredibility subcomponent of the CEQ (items 1 to 3) [24]; ranges from 1 (least credible) to 9 (most credible)
  6. eExpectancy subcomponent of the CEQ (items 4 to 6) [24]; ranges from 1 (lowest expectancy) to 9 (highest expectancy)
  7. fCredibility and expectancy subcomponents of the CEQ, combined [24] (items 1 to 6); ranges from 1 (least credible and lowest expectancy) to 9 (most credible and highest expectancy)
  8. gChange in device-measured observer-reported ROM measurements between baseline and post-study visit 2 using the iOS application Measure® (iOS version 16.0.2, iPhone® model X, Apple Inc., California, United States) [24]; higher positive values indicate larger positive change in ROM